IMMUNE THROMBOCYTOPENIA
Clinical trials for IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical cell therapy trial aims to reset the immune system
Disease control Not yet recruitingThis study is testing a new type of cell therapy called CD19 UCAR-T in people with various autoimmune diseases that haven't responded well to standard treatments. The main goals are to see if the treatment is safe and if it can help control the diseases. It will involve a small g…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New drug combo tested to stop dangerous bleeding disorder
Disease control Not yet recruitingThis study aims to find the safest and most effective dose of the drug zanubrutinib when given with a steroid (dexamethasone) to adults newly diagnosed with immune thrombocytopenia (ITP). ITP is a condition where the immune system attacks platelets, increasing the risk of bruisin…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Blood test breakthrough could end diagnostic confusion for bleeding disorders
Diagnosis Not yet recruitingThis study aims to find a better way to tell apart two similar conditions that cause low platelets and bleeding risk: primary immune thrombocytopenia (ITP) and low platelets caused by lupus (SLE). Researchers will test blood samples from 300 adults to see if measuring levels of t…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Sohag University • Aim: Diagnosis
Last updated Mar 16, 2026 15:24 UTC